AU
UK
CA
NZ
IND
US
Last update at 2026-05-07T21:17:54.920878Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Form 8.3 - ASSURA PLC - AMENDMENT
Wed 23 Jul 25, 02:00 PMAssura Group Rejects KKR & Co. Inc. (KKR) Takeover Bid in Favor of Competitor $2.4 Billion Offer
Mon 30 Jun 25, 01:47 AMTrending tickers: Nvidia, Alibaba, Novavax, Ryanair and Diageo
Mon 19 May 25, 10:00 AMFTSE 100 recovers to pre-trade tariff announcement levels
Fri 16 May 25, 04:06 PMNHS landlord Assura attracts new offer from PHP as bidding war heats up
Fri 16 May 25, 01:28 PMGP surgeries owner Assura agrees to private equity takeover worth £1.61bn
Wed 09 Apr 25, 07:00 AMUK's Assura agrees to $2.06 billion takeover by KKR-Stonepeak
Wed 09 Apr 25, 06:21 AMUK's Assura shares rise on $2.08 billion bid from KKR, Stonepeak
Mon 10 Mar 25, 07:22 AMUK's Assura rejects $2 billion buyout bid from KKR, pension fund
Mon 17 Feb 25, 07:32 AM| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 166.00M | -28.70000M | -119.20000M | 155.80M | 108.30M |
| Minority interest | - | - | - | - | - |
| Net income | 166.00M | -28.80000M | -119.20000M | 155.90M | 108.30M |
| Selling general administrative | 5.30M | 5.60M | 13.30M | 11.70M | 13.50M |
| Selling and marketing expenses | - | 0.80M | - | - | - |
| Gross profit | 167.10M | 143.30M | 138.00M | 126.50M | 112.00M |
| Reconciled depreciation | - | 0.30M | - | - | - |
| Ebit | - | -1.60000M | - | 114.10M | 100.50M |
| Ebitda | 207.60M | -1.30000M | -91.70000M | 182.30M | 132.40M |
| Depreciation and amortization | - | 0.30M | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | 152.00M | 129.30M | -91.70000M | 182.30M | 132.40M |
| Other operating expenses | 31.80M | 28.50M | 26.40M | 22.80M | 22.80M |
| Interest expense | 41.60M | 27.10M | 26.80M | 26.50M | 24.10M |
| Tax provision | 0.00000M | 0.10M | 0.00000M | -0.10000M | 0.00000M |
| Interest income | 1.70M | 2.10M | 1.60M | 0.40M | 0.20M |
| Net interest income | -42.90000M | -27.20000M | -27.30000M | -28.00000M | -32.20000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | - | 0.10M | - | -0.10000M | - |
| Total revenue | 183.80M | 157.80M | 150.40M | 136.90M | 120.80M |
| Total operating expenses | 15.10M | 14.00M | 14.00M | 12.40M | 14.00M |
| Cost of revenue | 16.70M | 14.50M | 12.40M | 10.40M | 8.80M |
| Total other income expense net | 14.00M | -158.00000M | -27.50000M | -26.50000M | -24.10000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 166.00M | -28.80000M | -119.20000M | 155.90M | 108.30M |
| Net income applicable to common shares | - | - | - | 155.90M | 108.30M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 3281.40M | 2812.20M | 2922.60M | 3120.50M | 2557.10M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 21.50M | 19.20M | 2.30M | 77.90M | 16.40M |
| Total liab | 1639.00M | 1339.10M | 1335.10M | 1330.90M | 1026.40M |
| Total stockholder equity | 1642.40M | 1473.10M | 1587.50M | 1789.60M | 1530.70M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 83.40M | 76.50M | 30.60M | 30.10M | 25.40M |
| Common stock | 325.10M | 298.50M | 296.10M | 294.80M | 267.20M |
| Capital stock | 325.10M | 298.50M | 296.10M | 294.80M | 267.20M |
| Retained earnings | 73.50M | 10.90M | 135.30M | 345.10M | 269.20M |
| Other liab | - | - | - | 6.00M | 6.10M |
| Good will | - | - | - | - | - |
| Other assets | - | - | - | 0.60M | 0.50M |
| Cash | 55.30M | 33.20M | 118.00M | 243.50M | 46.60M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 160.30M | 82.40M | 77.80M | 75.10M | 66.20M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 1489.60M | 1219.60M | 1134.60M | 1006.40M | 907.60M |
| Short term debt | 70.10M | 0.30M | 0.40M | 0.10M | 0.10M |
| Short long term debt | 70.00M | - | - | - | 0.00000M |
| Short long term debt total | 1544.90M | 1252.80M | 1252.60M | 1249.90M | 954.20M |
| Other stockholder equity | 1243.80M | 932.70M | 1156.10M | 1149.70M | 994.30M |
| Property plant equipment | - | - | - | 2767.60M | 2467.20M |
| Total current assets | 117.10M | 73.10M | 151.50M | 348.50M | 88.70M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 1789.60M | 1530.70M |
| Short term investments | - | - | - | - | - |
| Net receivables | 40.30M | 20.70M | 33.10M | 27.20M | 26.00M |
| Long term debt | 1469.60M | 1246.90M | 1246.40M | 1244.40M | 948.70M |
| Inventory | - | 0.00000M | - | - | - |
| Accounts payable | 2.00M | 1.70M | 46.80M | 44.90M | 40.70M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | 231.00M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 3162.40M | 2718.40M | 2770.20M | 2770.90M | 2467.60M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 3164.30M | 2739.10M | 2771.10M | 2772.00M | 2468.40M |
| Capital lease obligations | 5.30M | 5.90M | 6.20M | 5.50M | 5.50M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -284.10000M | -97.70000M | -130.40000M | -3.50000M | -0.70000M |
| Change to liabilities | - | - | 0.00000M | 0.00000M | 0.00000M |
| Total cashflows from investing activities | -284.10000M | -97.70000M | - | -293.90000M | -267.50000M |
| Net borrowings | - | - | - | 295.90M | 108.10M |
| Total cash from financing activities | 196.30M | -87.30000M | -89.20000M | 396.20M | 218.20M |
| Change to operating activities | - | - | 1.20M | 8.40M | 9.50M |
| Net income | 166.00M | -28.70000M | -119.20000M | 155.90M | 108.30M |
| Change in cash | 22.70M | -82.60000M | -125.50000M | 196.90M | 28.10M |
| Begin period cash flow | 35.40M | 118.00M | 243.50M | 46.60M | 18.50M |
| End period cash flow | 58.10M | 35.40M | 118.00M | 243.50M | 46.60M |
| Total cash from operating activities | 110.50M | 102.40M | - | 94.60M | 77.40M |
| Issuance of capital stock | - | - | 0.00000M | 182.60M | 186.00M |
| Depreciation | - | 0.30M | 0.20M | 0.20M | 0.10M |
| Other cashflows from investing activities | -247.20000M | -97.70000M | - | - | - |
| Dividends paid | 93.30M | 85.50M | -88.90000M | -75.40000M | -61.90000M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | - | -4.30000M | -4.40000M | -0.90000M | -5.20000M |
| Sale purchase of stock | - | - | - | - | 290.50M |
| Other cashflows from financing activities | -2.40000M | -1.80000M | -0.30000M | 309.00M | 284.10M |
| Change to netincome | - | - | 214.20M | -70.90000M | -36.90000M |
| Capital expenditures | 18.80M | 69.40M | 57.90M | 63.70M | 57.60M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | - | -0.60000M | - | - | - |
| Stock based compensation | - | 0.50M | - | - | - |
| Other non cash items | 110.50M | 130.90M | - | - | - |
| Free cash flow | 91.70M | 33.00M | -57.90000M | -63.70000M | -57.60000M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ARSSF Assura Plc |
- -% | - | 9.69 | 14.20 | 11.99 | 1.00 | 16.47 | 14.58 |
| WELL Welltower Inc |
6.22 2.94% | 217.67 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
2.33 2.81% | 85.37 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
| DOC Healthpeak Properties Inc |
0.58 2.90% | 20.56 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
| AHR American Healthcare REIT, Inc. |
1.51 3.20% | 48.67 | 117.90 | 61.73 | 4.21 | 2.90 | 4.96 | 31.16 |
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G). As of September 10, 2025, Assura Plc operates as a subsidiary of Primary Health Properties Plc.
3 Barrington Road, Altrincham, United Kingdom, WA14 1GY
| Name | Title | Year Born |
|---|---|---|
| Mr. Jonathan Stewart Murphy ACA, MBA | CEO & Exec. Director | 1972 |
| Ms. Jayne Marie Cottam | CFO & Exec. Director | 1974 |
| Ms. Amanda Roddy | Sr. Investment Mang. | NA |
| Ms. Joanne Cullen | Sr. Management Accountant | NA |
| Mr. David Purcell | Head of Investor Relations | NA |
| Ms. Orla Ball | Head of Legal & Company Sec. | NA |
| Ms. Debbie Chalcraft | Group Compliance Mang. | NA |
| Ms. Francesca Harris | Marketing Mang. | NA |
| Mr. Patrick Lowther | Head of Strategy & Markets | NA |
| Mr. Simon Oborn | Head of Property Management & Investment | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...